3 results
425
EX-99.1
LakeShore Biopharma Co., Ltd
30 Sep 22
Business combination disclosure
9:25am
with Summit’s solicitation of proxies for its special meeting of shareholders to be held to approve, among other things, the proposed Transaction, because
425
LakeShore Biopharma Co., Ltd
30 Sep 22
Business combination disclosure
9:25am
special meeting of shareholders to be held to approve, among other things, the proposed transaction, because these documents will contain important
425
EX-99.2
LakeShore Biopharma Co., Ltd
30 Sep 22
Business combination disclosure
9:25am
and, once available, the definitive proxy statement/prospectus, in connection with Summit’s solicitation of proxies for its special meeting
- Prev
- 1
- Next